Lateralization of 17beta-hydroxysteroid dehydrogenase type 10 in hippocampi of demented and psychotic people

Dementia and Geriatric Cognitive Disorders

Volumn 26, Issue 3, 2008, Pages 193-198

  Hovorkova, Petra ^a   Kristofikova, Zdena ^a,d   Horinek, Ales ^a   Ripova, Daniela ^a   Majer, Emerich ^b   Zach, Petr ^a   Sellinger, Pavel ^c   Ricny, Jan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Servier sro   (Czech Republic)

^c UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

Alzheimer disease; Amyloid binding protein; Brain laterality; Multi infarct dementia; Postmortem tissue; Schizophrenia

Indexed keywords

AMYLOID BETA PROTEIN; MESSENGER RNA; MITOCHONDRIAL ENZYME; TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE 17BETA DEHYDROGENASE TYPE 10; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; ASYMMETRIC CATALYSIS; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LEFT HEMISPHERE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSIS; SCHIZOPHRENIA;

3-HYDROXYACYL COA DEHYDROGENASES; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CEREBRAL INFARCTION; FEMALE; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; PSYCHOTIC DISORDERS; RNA, MESSENGER;

EID: 50549092277     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151778     Document Type: Article

References (25)

1. Wirths O, Multhaup G, Bayer TA: A modified β-amyloid hypothesis: intraneuronal accumulation of the β-amyloid peptide - the first step of a fatal cascade. J Neurochem 2004;91:513-520.
2. Parihar MS, Brewer GJ: Mitoenergetic failure in Alzheimer disease. Am J Physiol Cell Physiol 2007;292:8-23.
3. Lovell MA, Xiong S, Markesbery WR, Lynn BC: Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide. Neurochem Res 2005;30:113-122.
4. Yan SD, Shi Y, Zhu A, Fu J, Zhu H, Zhu Y, Gibson L, Stern E, Collison K, Al-Mohanna F, Ogawa S, Roher A, Clarce SG, Stern DM: Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Aβ-induced cytotoxicity. J Biol Chem 1999;274:2145-2156.
5. Oppermann UCD, Salim S, Tjernberg LO, Terenius L, Jörnvall H: Binding of amyloid β-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease. FEBS Lett 1999;451:238-242.
6. Yan SD, Stern DM: Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-β peptide alcohol dehydrogenase (ABAD). Int J Exp Path 2005;86:161-171.
7. He XY, Wen GY, Merz G, Lin D, Yang YZ, Mehta P, Schulz H, Yang YZ: Abundant type 10 17β-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model. Mol Brain Res 2002;99:46-53.
8. Wiltfang J, Lewczuk P, Riederer P, Grünblatt E, Hock C, Scheltens P, Hampel H, Vanderstichele H, Iqbal K, Galasko D, Lannfelt L, Otto M, Esselmann H, Henkel AW, Kornhuber J, Blennow K: Consensus paper of the WFSBP task force on biological markers of dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World J Biol Psychiatry 2005;6:69-84.
9. Frey HJ, Mattila KM, Korolainen MA, Pirttilä T: Problems associated with biological markers of Alzheimer's disease. Neurochem Res 2005;30:1501-1510.
10. Chan PH: Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia. Neurochem Res 2004;29:1943-1949.
11. Ben-Shachar D: Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem 2002;83:1241-1251.
12. Toga AW, Thompson PM: Mapping brain asymmetry. Nat Neurosci 2003;4:37-48.
13. Ramírez M, Prieto I, Vives F, de Gasparo M, Alba F: Neuropeptides, neuropeptidases and brain asymmetry. Curr Protein Pept Sc 2004;5:497-506.
14. 3H)Hemicholinium-3 binding sites in postmortem brains of human patients with Alzheimer's disease and multi-infarct dementia. Exp Gerontol 1995;30:125-136.
15. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The consortium to establish a registry for Alzheimer's disease (CERAD). Neurology 1991;41:479-486.
16. Zach P, Krištofiková Z, Majer E, Selinger P, ŘípováD: Alterations in the planum temporale in patients with Alzheimer disease estimated via a new volumetric method; in Fisher A, Hanin I, Memo M, Stocchi F (eds): New Trends in Alzheimer and Parkinson Related Disorders . Bologna, Medimond, 2005, pp 171-176.
17. Herbison AE, Augood SJ, Simonian SX, Chapman C: Regulation of GABA transporter activity and mRNA expression by estrogen in rat preoptic area. J Neurosci 1995;15:8302-8309.
18. He XY, Merz G, Yang YZ, Mehta P, Schultz H, Yang SY: Characterization and localization of human type 10 17β-hydroxysteroid dehydrogenase. Eur J Biochem 2001;268:4899-4907.
19. Tang AC: A hippocampal theory of cerebral lateralization; in Hugdahl K, Davidson RJ (eds): The Asymmetrical Brain. Cambridge, MIT Press, 2003, pp 37-68.
20. Hajszan T, Milner TA, Leranth C: Sex steroids and the dentate gyrus. Prog Brain Res 2007;163:399-415.
21. Pfluger T, Weil S, Weis S, Vollmar C, Heiss D, Egger J, Scheck R, Hahn K: Normative volumetric data of the developing hippocampus in children based on magnetic resonance imaging. Epilepsia 1999;40:414-423.
22. Maarouf FDL, Roubertoux PL, Carlier M: Is mitochondrial DNA involved in mouse behavioral laterality? Behav Genet 1999;29:311-318.
23. Religa D, Laudon H, Styczynska M, Winblad B, Näslund J, Haroutunian V: Amyloid β pathology in Alzheimer's disease and schizophrenia. Am J Psychiatry 2003;160:867-872.
24. Traver S, Ardila-Osorio H, Périquet M, Hampe C, Brice A, Corti O: Parkin linked to mitochondria: identification of a novel substrate. http://users.unimi.it/triplet/2007/2007:S6.
25. Stomrud E, Hansson O, Blennow K, Minthon L, Londos E: Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly. Dement Geriatr Cogn Disord 2007;24:118-124.